Jan J. Jobsen

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

Carien L. Creutzberg, W L van Putten, P. Koper et al. · The Lancet · 2000 · 1.8K citations

Medicine, Oncology, Surgery +11

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse et al. · Clinical Cancer Research · 2016 · 858 citations

Medicine, Gynecology, Oncology +17

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 623 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

Nicholas Reed, Costantino Mangioni, Henric Malmström et al. · European Journal of Cancer · 2008 · 531 citations

Medicine, Oncology, Radiation Oncology +13

10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

Marissa C. van Maaren, Linda de Munck, Geertruida H. de Bock et al. · The Lancet Oncology · 2016 · 435 citations · Full text

Medicine, Oncology, Surgery +13